Follow-up pharmacodynamic experiments demonstrated that EJ significantly inhibited metastasis of cancer cells both in vitro and in vivo, and that the protein levels of STAT3, MMP-2, and MMP-9 could be dose-dependently reduced by EJ. Here, STAT3 is linked to cancer.